OECD's Routine Profits Pricing Plan Falls Short, Tax Pros Say

News

• 5 月 30 日

  2023 年

  Mayer Brown advised SERB Pharmaceuticals on the structuring of the acquisition of the US rights to bentracimab, a ticagrelor reversal agent, from SFJ Pharmaceuticals

• 5 月 08 日

  2023 年

  Mayer Brown adds former IRS international tax lawyer Sonal Majmudar

• 5 月 05 日

  2023 年

  Mayer Brown advises new client Sullivan Street Partners alongside Souter Investments on their acquisition of the diagnostic services business of Johnson Matthey, Tracerco

• 4 月 24 日

  2023 年

  Mayer Brown advises TUI on the sale of its stake in Peakwork AG

• 3 月 30 日

  2023 年

  Mayer Brown advises AIF Capital Group on the acquisition of three care facilities in Lübeck, Sulzbach and Wetzlar